Literature DB >> 22540299

Somatic deletions of the polyA tract in the 3' untranslated region of epidermal growth factor receptor are common in microsatellite instability-high endometrial and colorectal carcinomas.

Ma Deqin1, Zhao Chen, Christopher Nero, Keyur P Patel, Emad M Daoud, Hanyin Cheng, Bojana Djordjevic, Russell R Broaddus, L Jeffrey Medeiros, Asif Rashid, Rajyalakshmi Luthra.   

Abstract

CONTEXT: Epidermal growth factor receptor (EGFR) is overexpressed in up to 80% of colorectal and endometrial carcinomas. Deletions of the polyA tract in the 3' untranslated region (3' UTR) have been reported in microsatellite instability-high (MSI-H) colonic carcinomas, but their impacts on EGFR expression and downstream pathways are unclear. This phenomenon has not been reported in other MSI-H tumors.
OBJECTIVE: To assess the 3' UTR polyA tract of EGFR in both endometrial and colorectal carcinomas and the mutational status of EGFR downstream pathways.
DESIGN: Ninety-eight colorectal carcinomas and 47 endometrial carcinomas were included. EGFR 3' UTR polyA status was detected by capillary electrophoresis and Sanger sequencing. EGFR gene expression, EGFR copy numbers, and KRAS and BRAF mutation status were analyzed accordingly.
RESULTS: The 3' UTR polyA tract was deleted in 18 of 23 (78%) MSI-H versus 0 of 24 microsatellite-stable endometrial carcinomas (P < .001). Similar observations were seen in colorectal carcinomas, in which 29 of 36 (81%) MSI-H, 1 of 62 (1.6%) microsatellite instability-low, and none of the microsatellite-stable tumors harbored the deletion (P < .001). A moderate increase in EGFR mRNA level was observed in endometrial carcinomas with 3' UTR polyA deletions versus those with wild-type polyA tract. Amplification of the EGFR gene was not observed. Deletions in polyA tract do not seem to affect the frequency of KRAS and BRAF mutations.
CONCLUSIONS: Deletions of EGFR 3' UTR polyA are frequent in endometrial and colorectal carcinomas, are confined almost exclusively to MSI-H tumors, and do not affect KRAS and BRAF mutations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22540299      PMCID: PMC3807134          DOI: 10.5858/arpa.2010-0638-OA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  30 in total

Review 1.  The 3' untranslated region of messenger RNA: A molecular 'hotspot' for pathology?

Authors:  B Conne; A Stutz; J D Vassalli
Journal:  Nat Med       Date:  2000-06       Impact factor: 53.440

2.  Strategies for genotyping: Effectiveness of tailing primers to increase accuracy in short tandem repeat determinations.

Authors:  Linda Wood Ballard; Pamela Scott Adams; Yongde Bao; Duane Bartley; Doug Bintzler; Laura Kasch; Lynn Petukhova; Caprice Rosato
Journal:  J Biomol Tech       Date:  2002-03

3.  Evaluation of malignancy and the prognosis of esophageal cancer based on an immunohistochemical study (p53, E-cadherin, epidermal growth factor receptor).

Authors:  S Inada; T Koto; K Futami; S Arima; A Iwashita
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

4.  Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis.

Authors:  Reade B Roberts; Lu Min; M Kay Washington; Sandra J Olsen; Stephen H Settle; Robert J Coffey; David W Threadgill
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

5.  Characterization of a mouse ctgf 3'-UTR segment that mediates repressive regulation of gene expression.

Authors:  S Kondo; S Kubota; T Eguchi; T Hattori; T Nakanishi; T Sugahara; M Takigawa
Journal:  Biochem Biophys Res Commun       Date:  2000-11-11       Impact factor: 3.575

6.  Increasing epidermal growth factor receptor expression in human melanocytic tumor progression.

Authors:  P E de Wit; S Moretti; P G Koenders; M A Weterman; G N van Muijen; B Gianotti; D J Ruiter
Journal:  J Invest Dermatol       Date:  1992-08       Impact factor: 8.551

7.  An A13 repeat within the 3'-untranslated region of epidermal growth factor receptor (EGFR) is frequently mutated in microsatellite instability colon cancers and is associated with increased EGFR expression.

Authors:  Ziqiang Yuan; Joongho Shin; Andrew Wilson; Sanjay Goel; Yi-He Ling; Naseem Ahmed; Higinio Dopeso; Minaxi Jhawer; Shannon Nasser; Cristina Montagna; Kenneth Fordyce; Leonard H Augenlicht; Lauri A Aaltonen; Diego Arango; Thomas K Weber; John M Mariadason
Journal:  Cancer Res       Date:  2009-09-29       Impact factor: 12.701

Review 8.  Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities.

Authors:  Helmout Modjtahedi; Sharadah Essapen
Journal:  Anticancer Drugs       Date:  2009-11       Impact factor: 2.248

9.  Epidermal growth factor receptor and prognosis in human breast cancer: a prospective study.

Authors:  P G Koenders; L V Beex; C B Kienhuis; P W Kloppenborg; T J Benraad
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

10.  Epidermal growth factor receptor levels are lower in carcinomatous than in normal colorectal tissue.

Authors:  P G Koenders; W H Peters; T Wobbes; L V Beex; F M Nagengast; T J Benraad
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

View more
  6 in total

1.  Next-generation sequencing-based multigene mutational screening for acute myeloid leukemia using MiSeq: applicability for diagnostics and disease monitoring.

Authors:  Rajyalakshmi Luthra; Keyur P Patel; Neelima G Reddy; Varan Haghshenas; Mark J Routbort; Michael A Harmon; Bedia A Barkoh; Rashmi Kanagal-Shamanna; Farhad Ravandi; Jorge E Cortes; Hagop M Kantarjian; L Jeffrey Medeiros; Rajesh R Singh
Journal:  Haematologica       Date:  2013-10-18       Impact factor: 9.941

Review 2.  Endometrial tumour BRAF mutations and MLH1 promoter methylation as predictors of germline mismatch repair gene mutation status: a literature review.

Authors:  Alexander M Metcalf; Amanda B Spurdle
Journal:  Fam Cancer       Date:  2014-03       Impact factor: 2.375

3.  Oncogenic mutations and microsatellite instability phenotype predict specific anatomical subsite in colorectal cancer patients.

Authors:  Giovanni Corso; Valeria Pascale; Giuseppe Flauti; Francesco Ferrara; Daniele Marrelli; Franco Roviello
Journal:  Eur J Hum Genet       Date:  2013-04-10       Impact factor: 4.246

4.  Characteristics of genomic mutations and signaling pathway alterations in thymic epithelial tumors.

Authors:  Weilin Yang; Sai Chen; Zhenguang Chen; Xinxin Cheng; Bo Xu; Huilan Zeng; Jianyong Zou; Chunhua Su
Journal:  Ann Transl Med       Date:  2021-11

5.  Genetic variations of the A13/A14 repeat located within the EGFR 3' untranslated region have no oncogenic effect in patients with colorectal cancer.

Authors:  Nasrin Sarafan-Vasseur; David Sefrioui; David Tougeron; Aude Lamy; France Blanchard; Florence Le Pessot; Frédéric Di Fiore; Pierre Michel; Stéphane Bézieau; Jean-Baptiste Latouche; Thierry Frebourg; Richard Sesboüé
Journal:  BMC Cancer       Date:  2013-04-08       Impact factor: 4.430

6.  Target gene mutational pattern in Lynch syndrome colorectal carcinomas according to tumour location and germline mutation.

Authors:  Manuela Pinheiro; Carla Pinto; Ana Peixoto; Isabel Veiga; Paula Lopes; Rui Henrique; Helena Baldaia; Fátima Carneiro; Raquel Seruca; Ian Tomlinson; Michal Kovac; Karl Heinimann; Manuel R Teixeira
Journal:  Br J Cancer       Date:  2015-08-06       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.